BVIKM - 30ste Symposium

30ste Symposium

WHAT WILL CHANGE IN YOUR DAILY PRACTICE WITH THE NEW EUCAST BREAKPOINTS FOR ANTIBIOTIC SUSCEPTIBILITY TESTING?

European breakpoints and EUCAST, what next? [Gunnar KAHLMETER (Central Hospital, Växjö, Finland)]
PK-PD as a basis for clinically relevant breakpoints. [Paul TULKENS (UCL, Brussel)]
Introduction of new breakpoints in the labs: challenges and solutions. [Pierrette MELIN (CHU de Liège, Luik)]
Epidemiological consequences of new breakpoints. [Greet IEVEN (UZ Antwerpen, Antwerpen)]
Consequences for the clinicians. [Yves VAN LAETHEM (UMC Sint-Pieter, Brussel)]